1,2,3,7,8,9-Hexachlorodibenzodioxin
CAS: 19408-74-3
Ref. 3D-FH23773
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued |
Product Information
- 1,2,3,7,8,9-Hexachlorodibenzo[b,e][1,4]dioxin1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin
- 1,2,3,7,8,9-Hcdd
- 1,2,3,7,8,9-Hexachloro-Dibenzo-P-Dioxi
- 1,2,3,7,8,9-Hexachlorodibenzo(B,E)(1,4)Dioxin
- 1,2,3,7,8,9-Hexachlorodibenzo[1,4]dioxin
- 1,2,3,7,8,9-Hexachlorooxanthrene
- 1,2,3,7,8,9-Hxcdd
- D 70
- Dibenzo-Para-Dioxin,Hexachloro-
- Dibenzo-p-dioxin, 1,2,3,7,8,9-hexachloro-
- See more synonyms
- Dibenzo[b,e][1,4]dioxin, 1,2,3,7,8,9-hexachloro-
- Pcdd 70
- d70
Hexachlorodibenzodioxin (HCBD) is a polychlorinated dibenzo-p-dioxin and has been classified as one of the most toxic compounds known to man. HCBD is an environmental contaminant that has been linked to many human diseases, including infectious diseases and chronic exposure. It is considered an endocrine disruptor because it may interfere with the function of sex hormone receptors by binding to them. HCBD has also been shown to cause liver lesions in rats at high doses. The chemical can be detected in body fat and serum, but not in urine or saliva, which makes it difficult to analyze. The most common analytical method for HCBD is gas chromatography followed by electron capture detection. In addition, HCBD inhibits the activity of several enzymes involved in fatty acid metabolism, leading to a decrease in cellular energy production and an increase in fat accumulation.
